找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Essential Pharmaceutics; Ashlee D. Brunaugh,Hugh D. C. Smyth,Robert O. Will Textbook 2019 American Association of Pharmaceutical Scientist

[復(fù)制鏈接]
樓主: 方面
31#
發(fā)表于 2025-3-27 00:03:26 | 只看該作者
https://doi.org/10.1007/0-387-28273-4e discussed, including particle settling, flocculation, particle aggregation, viscosity, zeta potential, and Ostwald ripening are discussed. Methods of particle size reduction are introduced, including those to produce nanoparticles. An extensive discussion of relevant excipients is also included.
32#
發(fā)表于 2025-3-27 02:06:58 | 只看該作者
Why Technical Solutions are Insufficientanisms for drug transport through the skin, in vitro analytical techniques, and methods to increase drug permeation. Commonly used formulation approaches such as semisolid dosage forms and transdermal patches are also discussed.
33#
發(fā)表于 2025-3-27 08:15:41 | 只看該作者
https://doi.org/10.1007/978-94-011-4321-9, as are the mechanisms for overcoming these barriers through delivery device and formulation design. A review is provided of delivery mechanisms and design of the three major classes of pulmonary drug delivery devices (pressurized metered dose inhalers, nebulizers, and dry powder inhalers). For eac
34#
發(fā)表于 2025-3-27 12:17:47 | 只看該作者
35#
發(fā)表于 2025-3-27 16:48:32 | 只看該作者
AAPS Introductions in the Pharmaceutical Scienceshttp://image.papertrans.cn/e/image/315504.jpg
36#
發(fā)表于 2025-3-27 17:48:21 | 只看該作者
37#
發(fā)表于 2025-3-27 23:15:49 | 只看該作者
38#
發(fā)表于 2025-3-28 02:51:19 | 只看該作者
Capsule and Tablet Dosage Forms,egories are provided along with general functions and examples. A review of USP-recommended analytical tests is also included. Lastly, this chapter introduces techniques for formulating poorly water soluble drugs in capsule and tablet dosage forms.
39#
發(fā)表于 2025-3-28 09:46:44 | 只看該作者
Pulmonary Drug Delivery,design of the three major classes of pulmonary drug delivery devices (pressurized metered dose inhalers, nebulizers, and dry powder inhalers). For each class of device, appropriate formulation approaches are discussed.
40#
發(fā)表于 2025-3-28 13:05:30 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-20 18:36
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
滨州市| 宽甸| 凉城县| 永嘉县| 江门市| 永和县| 东港市| 宁夏| 金寨县| 绥中县| 弥渡县| 桐梓县| 和顺县| 罗甸县| 顺平县| 大悟县| 凤庆县| 静乐县| 克东县| 兰考县| 安多县| 临泽县| 巴马| 澳门| 六枝特区| 霍邱县| 长寿区| 东乡族自治县| 正蓝旗| 磐石市| 犍为县| 曲靖市| 庄浪县| 吐鲁番市| 闵行区| 浦江县| 武功县| 黄骅市| 仙居县| 万山特区| 宜宾县|